4D Molecular Therapeutics (NasdaqGS:FDMT) FY Conference Transcript

4D Molecular Therapeutics (NasdaqGS:FDMT) FY Conference September 09, 2025 01:50 PM ET Company ParticipantsDavid Kirn - CEOChristopher Simms - CFOConference Call ParticipantsJudah C. Frommer - Senior Equity Research AnalystJudah C. FrommerOn to this session of the Morgan Stanley Global Healthcare Conference. I'm excited to welcome the team from 4D Molecular Therapeutics. Let me just get through a quick disclosure before we get started. For important disclosures, please see the Morgan Stanley Research Disclo ...